Page last updated: 2024-08-23

perfosfamide and Osteosarcoma

perfosfamide has been researched along with Osteosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colvin, M; Duan, X; Jia, SF; Kleinerman, ES; Lafleur, EA; Zhou, Z	1

Other Studies

1 other study(ies) available for perfosfamide and Osteosarcoma

Article	Year
Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-15, Volume: 10, Issue:2 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Separation; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Immunohistochemistry; Inhibitory Concentration 50; Interleukin-12; Membrane Glycoproteins; Methotrexate; Osteosarcoma; RNA, Messenger; Time Factors; Transfection; Up-Regulation	2004

Article

Year

Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-15, Volume: 10, Issue:2

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Separation; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Immunohistochemistry; Inhibitory Concentration 50; Interleukin-12; Membrane Glycoproteins; Methotrexate; Osteosarcoma; RNA, Messenger; Time Factors; Transfection; Up-Regulation

2004